Article thumbnail

Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy

By P Österlund, L-M Soveri, H Isoniemi, T Poussa, T Alanko and P Bono
Topics: Clinical Study
Publisher: Nature Publishing Group
OAI identifier: oai:pubmedcentral.nih.gov:3049598
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2009). Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma.
  2. (2004). Oncol 28(6): 949–954 Dvorak HF (2002) Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20(21): 4368–4380